Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK
Context Ellagic acid (EA) is used in traditional medicine to treated hyperlipidaemia. Objective This study examined if AMPK mediates the anti-steatotic effect of ellagic acid (EA) in streptozotocin (STZ)-induced type 1 diabetes mellitus in rats. Materials and methods Adult male Wistar rats (130 ± 10...
Saved in:
Main Authors: | Jozaa Z. ALTamimi (Author), Ghedeir M. Alshammari (Author), Nora A. AlFaris (Author), Reham I. Alagal (Author), Dalal H. Aljabryn (Author), Norah A. Albekairi (Author), Mahmoud Ahmad Alkhateeb (Author), Mohammed Abdo Yahya (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2
by: Jozaa Z. AlTamimi, et al.
Published: (2023) -
Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R
by: Jozaa Z. ALTamimi, et al.
Published: (2021) -
Physical Activity Levels of a Multi-Ethnic Population of Middle-Aged Men Living in Saudi Arabia and Factors Associated With Physical Inactivity
by: Nora A. AlFaris, et al.
Published: (2022) -
Physical Activity Levels of a Multi-Ethnic Population of Young Men Living in Saudi Arabia and Factors Associated With Physical Inactivity
by: Jozaa Z. AlTamimi, et al.
Published: (2022) -
Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Tharani Senavirathna, et al.
Published: (2024)